Latest News & Features
Americas
The Patent Trial and Appeal Board is not a “death squad” for drug patents, according to a study conducted by Fitzpatrick, Cella, Harper & Scinto. 15 June 2017
Americas
The US Court of Appeals for the Federal Circuit has affirmed a decision by the Patent Trial and Appeal Board (PTAB) which found that two patent applications by Purdue Pharma were unpatentable. 15 June 2017
Africa
The Competition Commission of South Africa has launched an investigation into suspected excessive pricing of cancer medicines by pharmaceutical companies Roche, Pfizer and Aspen Pharmacare. 14 June 2017
Americas
Brazil’s reforms to streamline analysis of pharmaceutical patents came into force on Monday. 14 June 2017
Americas
The US Supreme Court’s decision in the Amgen and Sandoz clash, which was handed down yesterday, has sparked disagreement between lawyers on the consequences of the ruling. 13 June 2017
Americas
The US Supreme Court has ruled that biosimilar applicants may provide notice to the manufacturer before obtaining a licence from the Food and Drug Administration for their biosimilars. 12 June 2017
Americas
Coherus BioSciences has asked a court to dismiss patent infringement allegations brought against it by Amgen. 12 June 2017
Americas
Medical device company QXMédical has filed a lawsuit against rival Vascular Solutions, denying infringement of Vascular’s patents. 12 June 2017
Americas
Eli Lilly has entered into a collaboration agreement with KeyBioscience, a subsidiary of Nordic Bioscience, to commercialise dual amylin calcitonin receptor agonists (DACRAs). 9 June 2017
Americas
The Patent Trial and Appeal Board has handed victory to hedge fund manager Kyle Bass in an inter partes review against a European healthcare company Fresenius Kabi-owned patent. 9 June 2017